Evelyn Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.92M Sell
181,498
-61,037
-25% -$2.83M 0.13% 89
2026
Q2
$10.4M Hold
242,535
– – 0.02% 84

Other funds holding BSX

Evelyn Partners's BSX Position: Q3 2026 in Review

Evelyn Partners reduced its Boston Scientific (BSX) stake by 25% in Q3 2026, selling an estimated $2.83M and leaving 181,498 shares worth $7.92M. The position accounts for 0.13% of the portfolio, ranked #89.

Evelyn Partners first reported a position in BSX in Q2 2026 and has held it in 2 quarters since. The position peaked at $10.4M in Q2 2026. 1,515 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Evelyn Partners held 181,498 shares of Boston Scientific worth $7.92M as of Q3 2026.
  • Evelyn Partners sold 61,037 Boston Scientific shares in Q3 2026, an estimated $2.83M.
  • Boston Scientific made up 0.13% of Evelyn Partners's portfolio in Q3 2026, its #89 holding.
  • Evelyn Partners first reported a position in Boston Scientific in Q2 2026 and has held it in 2 quarters since.
  • Evelyn Partners's Boston Scientific position peaked at $10.4M in Q2 2026.
  • 1,515 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Evelyn Partners's 13F filing for Q3 2026, filed 10 Nov 2026.